XORTX Therapeutics Inc. filed a Form 6-K on January 17, 2025, under the Securities Exchange Act of 1934. The filing indicates that they will continue to submit annual reports under Form 20-F.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.